165 related articles for article (PubMed ID: 15750834)
101. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
102. Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.
Aquino A; Graziani G; Franzese O; Prete SP; Bonmassar E; Bonmassar L; D'Atri S
Clin Dev Immunol; 2011; 2011():790460. PubMed ID: 21603161
[TBL] [Abstract][Full Text] [Related]
103. Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Tuyaerts S; Aerts JL; Corthals J; Neyns B; Heirman C; Breckpot K; Thielemans K; Bonehill A
Cancer Immunol Immunother; 2007 Oct; 56(10):1513-37. PubMed ID: 17503040
[TBL] [Abstract][Full Text] [Related]
104. Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma.
Hájek R; Butch AW
Med Oncol; 2000 Feb; 17(1):2-15. PubMed ID: 10713654
[TBL] [Abstract][Full Text] [Related]
105. In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
Schütt P; Buttkereit U; Brandhorst D; Lindemann M; Schmiedl S; Grosse-Wilde H; Seeber S; Nowrousian MR; Opalka B; Moritz T
Cancer Immunol Immunother; 2005 May; 54(5):506-12. PubMed ID: 15750834
[TBL] [Abstract][Full Text] [Related]
106. Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Ratta M; Curti A; Fogli M; Pantucci M; Viscomi G; Tazzari P; Fagnoni F; Vescovini R; Sansoni P; Tura S; Lemoli RM
Exp Hematol; 2000 Aug; 28(8):931-40. PubMed ID: 10989194
[TBL] [Abstract][Full Text] [Related]
107. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function.
Vuckovic S; Fearnley DB; Mannering SI; Dekker J; Whyte LF; Hart DN
Exp Hematol; 1998 Dec; 26(13):1255-64. PubMed ID: 9845382
[TBL] [Abstract][Full Text] [Related]
108. 1-alpha,25-Dihydroxyvitamin D3 (1,25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes.
Canning MO; Grotenhuis K; de Wit H; Ruwhof C; Drexhage HA
Eur J Endocrinol; 2001 Sep; 145(3):351-7. PubMed ID: 11517017
[TBL] [Abstract][Full Text] [Related]
109. Impaired circulating myeloid DCs from myeloma patients.
Do TH; Johnsen HE; Kjaersgaard E; Taaning E; Svane IM
Cytotherapy; 2004; 6(3):196-203. PubMed ID: 15203976
[TBL] [Abstract][Full Text] [Related]
110. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor.
Brossart P; Grünebach F; Stuhler G; Reichardt VL; Möhle R; Kanz L; Brugger W
Blood; 1998 Dec; 92(11):4238-47. PubMed ID: 9834229
[TBL] [Abstract][Full Text] [Related]
111. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells.
Deng L; Ding W; Granstein RD
J Invest Dermatol; 2003 Nov; 121(5):1060-5. PubMed ID: 14708607
[TBL] [Abstract][Full Text] [Related]
112. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
[TBL] [Abstract][Full Text] [Related]
113. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).
Reimer P; Kunzmann V; Wilhelm M; Weissbrich B; Kraemer D; Berghammer H; Weissinger F
Ann Hematol; 2003 May; 82(5):263-70. PubMed ID: 12739062
[TBL] [Abstract][Full Text] [Related]
114. Thalidomide and a thalidomide analogue drug costimulate virus-specific CD8+ T cells in vitro.
Haslett PA; Hanekom WA; Muller G; Kaplan G
J Infect Dis; 2003 Mar; 187(6):946-55. PubMed ID: 12660941
[TBL] [Abstract][Full Text] [Related]
115. Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells.
Xie J; Wang Y; Freeman ME; Barlogie B; Yi Q
Blood; 2003 May; 101(10):4005-12. PubMed ID: 12531797
[TBL] [Abstract][Full Text] [Related]
116.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
117.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
118.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
119.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
120.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
